Pharmaceutical manufacturing · Global partnerships

VERQUION MEDICARE

Care. Commitment. Cure.

An Indian pharmaceutical manufacturer and international B2B partner — building formulations, production capacity, and export relationships across healthcare markets.

Scroll

Company highlights

Scale built for retail, hospital, and export demand.

200+

Active retail & hospital partners

20 lakh

Net profit, as reported by the company

40%+

Quarter-on-quarter demand trajectory

Company-reported figures. Not independently audited or verified for this website.

About

A manufacturing company built for international partnership.

VERQUION MEDICARE develops, manufactures, and exports pharmaceutical formulations across domestic and international healthcare corridors. We work with distributors, Marketing Authorisation Holders, and institutional buyers who need reliable production, documentation, and supply.

The ambition is precise: to be recognised as a benchmark in generic manufacturing, scientific integrity, CTD regulatory compliance, and ethical patient care.

  1. 01 Pharmaceutical manufacturing
  2. 02 Product formulation
  3. 03 Contract manufacturing
  4. 04 Private label branding
  5. 05 Export support
  6. 06 Regulatory / CTD dossier support
  7. 07 Distribution partnerships
  8. 08 Institutional supply

The three-pillar philosophy

Care. Commitment. Cure.

Care

Placing patient health, clinical outcomes, and community wellness at the core of our corporate commitment.

Commitment

Strict adherence to WHO-GMP standards, bioequivalence, and CTD dossier preparation for export approvals.

Cure

Formulating evidence-based therapeutic products that transform lives worldwide.

Leadership

Directed from the board.

Director & CEO

Dr. Deepak Singh

Clinical pharmacology, regulatory filings, and international export strategy.

Director

Mr. Ankur Singh

Global supply chain operations, B2B distributor networks, and Marketing Authorisation Holder alliances.

Pharmaceutical manufacturing: automated tableting, liquid filling, cleanroom operations, and packaging lines.

Manufacturing

Production built to export standard.

State-of-the-art production at Plot No. 36, Pharma City, Selaqui, Dehradun, Uttarakhand, India.

  • High-speed automated tableting
  • Liquid syrup filling
  • Alu-Alu blister sealing
  • Cleanroom air handling
  • WHO-GMP
  • ISO 9001:2015
  • ICH Zone IVb stability standards for global exports

Featured brands

A focused portfolio for domestic and export markets.

BONEVIN-CZ packaging: carton, bottle, and Alu-Alu blister strip.

Bone health

BONEVIN-CZ™

Calcium 500mg + Zinc 7.5mg + Calcitriol 0.25mcg

High-strength calcium with zinc and calcitriol for bone mineral support, absorption, and immunity.

  • Post-menopausal osteoporosis
  • Bone fracture healing
  • Senile osteopenia
  • Chronic bone density loss
VITANOVA PLUS carton, gold-capped bottle of softgels, and blister strip.

Daily vitality

VITANOVA PLUS™

Lycopene 10% + Multivitamins + Multiminerals + Zinc + D3 & B12

A daily nutrition formula for nutritional gaps, oxidative stress, immune weakness, and convalescence.

  • Lycopene antioxidant support
  • Neuro-support with B12, B6, and niacinamide
  • Immunity defence with zinc, vitamin C, and D3
FERONOVA XT syrup carton and amber glass bottle with gold cap.

Hematinic elixir

FERONOVA XT™

Ferric Ammonium Citrate 160mg + B12 7.5mcg + Folic Acid 0.5mg Syrup

An iron tonic for iron-deficiency anemia, pregnancy and lactation anemia, post-surgical blood loss, and nutritional weakness.

  • Supports healthy red blood cell synthesis
  • Folic acid and B12 synergism
  • Mixed fruit flavour syrup

Gastro care

PANTORA-DSR™

Pantoprazole 40mg (EC) + Domperidone 30mg (SR)

Dual-action gastroprokinetic support for GERD, erosive esophagitis, hyperacidity, functional dyspepsia, and chronic gastritis.

  • Enteric-coated pantoprazole pellets
  • Sustained-release night-time coverage

Pain & edema relief

DOLOVER-SP™

Aceclofenac 100mg + Paracetamol 325mg + Serratiopeptidase 15mg

Triple-action support for post-operative pain, musculoskeletal trauma, osteoarthritis, rheumatoid arthritis, and sports injuries.

  • NSAID and analgesic combination
  • Serratiopeptidase for edema and recovery

Global presence

Target export markets across four corridors.

VERQUION MEDICARE is expanding CTD dossier presence across high-growth international pharmaceutical markets.

CIS & Eastern Europe

  • Uzbekistan
  • Kazakhstan
  • Tajikistan
  • Kyrgyzstan
  • Armenia
  • Georgia

Southeast Asia

  • Vietnam
  • Philippines
  • Myanmar
  • Cambodia
  • Sri Lanka

Middle East & GCC

  • UAE
  • Oman
  • Yemen
  • Iraq

Africa & Francophone West Africa

  • Kenya
  • Tanzania
  • Uganda
  • Nigeria
  • Ghana
  • Ivory Coast
  • DR Congo

Market focus

Country-by-country commercial intent.

Uzbekistan & Kazakhstan

BONEVIN-CZ™ and FERONOVA XT™ with CTD registration in progress.

Vietnam & Philippines

PANTORA-DSR™ and DOLOVER-SP™ via local MAH partners.

Sri Lanka & Myanmar

Direct tenders for hospital supply lines and essential generic medications.

UAE & Oman

Distribution agreements for VITANOVA PLUS™.

Nigeria, Kenya & Tanzania

High-volume supply of antimalarial support, antibiotics, and hematinics.

Ivory Coast & Ghana

Francophone multi-language blister pack distribution.

Partnerships

Four models for serious commercial alignment.

We structure relationships around territory, authorisation, institutional access, and manufacturing — not generic reseller programmes.

  1. 01

    Monopoly Franchise Distribution

    Exclusive regional rights for medical representatives, stockists, and pharma marketing firms.

  2. 02

    Export MAH Cooperation

    Marketing Authorisation Holder rights transfer and CTD dossier support for overseas importers.

  3. 03

    Institutional Government Tenders

    Direct supply contracts for hospital networks, clinical research institutes, and health ministries.

  4. 04

    Contract Manufacturing

    Custom formulation, tablet compression, and private label branding under WHO-GMP compliance.

Growth timeline

A deliberate sequence from incorporation to export filings.

  1. 2025 Q4

    Official Corporate Incorporation & MCA Approval

  2. 2026 Q1

    Launch of core brands BONEVIN-CZ, PANTORA-DSR, DOLOVER-SP at the Dehradun facility

  3. 2026 Q2

    Expansion to 200+ medical shops & hospital supply channels across India

  4. 2026–27

    CTD dossier filings in CIS, Southeast Asia, Middle East and African export markets

Begin a conversation

Partner with VERQUION.

Together, let’s deliver care, commitment, and cures worldwide.

Address
NH-28 Deoria Road, Kasia, Kushinagar,
Uttar Pradesh, India 274402
Facility
Plot No. 36, Pharma City, Selaqui,
Dehradun, Uttarakhand, India

B2B enquiry